New research reveals Millennials are most affected by a host of blood pressure raising factors and therefore are the fastest growing ‘at risk’ generation when it comes to developing hypertension. The survey of 2,000 respondents[1] by Kinetik Wellbeing, leaders in home blood pressure technology, was conducted...
Nottingham-based marketing and PR consultancy, V Formation, has recruited PR director, Diane Wood to lead its PR strategy and head up its new specialist PR team. Diane joins senior PR consultant and former senior business journalist, Lauren Mills, who joined the company in 2017 to strengthen...
Sygnature Discovery, a leading independent provider of integrated drug discovery and pre-clinical services and expertise, has today announced the next stage in its ambitious expansion plans with the addition of a new facility located at Alderley Park in Cheshire. This expansion will result in the doubling...
Medilink Midlands, a pan-regional strategic alliance between the Medilinks in the East and West Midlands, has recently been established to bring the collective expertise of the two organisations together to preserve the interests of over 1,700 Life Science organisations within the region and stimulate growth...
NuVision® are delighted to announce that they have signed a distribution agreement with Doctrinemed, a Turkish pharmaceutical and medical device company with a focus on ophthalmology. Doctrinemed will be working closely with NuVision in order to distribute our sight saving regenerative therapy, Omnigen® as well as...
3 August 2018 - Sygnature Discovery, a leading independent provider of integrated drug discovery and pre-clinical services and expertise, has proven its commitment to cyber security and the protection of its clients’ data by obtaining Cyber Essentials Plus certification. Launched by the UK Government in 2014,...
Nexus Labs, a pioneering medical education startup, today announced the completion of a Seed funding round to launch its first product, SurgicalTeaching.com a digital platform aimed at enhancing the learning experience of students and doctors around the world. The funding came from the GM&C Life...
Sygnature Discovery has appointed Dr Andy Black as non-executive Chairman. Andy will work closely with the Board and senior team to further develop the future growth strategy of the organisation. In October 2017, Phoenix Equity Partners, a leading private equity investor in medium-sized, UK-based companies, invested...
Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has appointed Andy Lindstrom as Director of Marketing to develop and lead the marketing strategy for the business. Andy holds a BA in Communications and Marketing from the University of Gävle, Sweden,...